182439-40-3

Basic information

• Product Name: [1,1'-Biphenyl]-2-carboxamide, N-[1-(phenylmethyl)-4-piperidinyl]-4'-(trifluoromethyl)-
• CAS NO: 182439-40-3
• Molecular Formula: C26H25F3N2O
• Molecular Weight: 438.493
• Mol File: 182439-40-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: [1,1'-Biphenyl]-2-carboxamide, N-[1-(phenylmethyl)-4-piperidinyl]-4'-(trifluoromethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: [1,1'-Biphenyl]-2-carboxamide, N-[1-(phenylmethyl)-4-piperidinyl]-4'-(trifluoromethyl)-(182439-40-3)
• EPA Substance Registry System: [1,1'-Biphenyl]-2-carboxamide, N-[1-(phenylmethyl)-4-piperidinyl]-4'-(trifluoromethyl)-(182439-40-3)

Safety Data

• Hazardous Substances Data: 182439-40-3(Hazardous Substances Data)

Usage

General Description

[1,1'-Biphenyl]-2-carboxamide, N-[1-(phenylmethyl)-4-piperidinyl]-4'-(trifluoromethyl)- is a compound with a complex chemical structure. It contains a biphenyl group connected to a carboxamide moiety, as well as a piperidinyl group and a trifluoromethyl group. [1,1'-Biphenyl]-2-carboxamide, N-[1-(phenylmethyl)-4-piperidinyl]-4'-(trifluoromethyl)- is likely to have a variety of chemical and biological properties due to its unique structure, with potential applications in pharmaceuticals, agrochemicals, and material science. Further research is needed to explore the specific properties and potential uses of this compound.

Upstream product

• 88-67-5 2-Iodobenzoic acid 
• 50541-93-0 4-amino-1-benzylpiperidine 
• 180340-74-3 4'-trifluoromethylbiphenyl-2-carbonyl chloride 
• 84392-17-6 4'-(trifluoromethyl)-2-biphenylcarboxylic acid 

Downstream Products

• 182431-12-5 9-[4-[4-[[[4'-(trifluoromethyl)[1,1'-biphenyl]-2-yl]carbonyl]amino]-1-piperidinyl]butyl]-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide 
• 182439-41-4 N-(1-piperidin-4-yl)-4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxamide 

Relevant articles and documents

AMORPHOUS FORM OF LOMITAPIDE MESYLATE

Provided is novel amorphous form of lomitapide mesylate salt and process for preparation thereof.

ESTER COMPOUND AND MEDICINAL USE THEREOF

A novel therapeutic agent for hyperlipidemia, which is an ester compound represented by the formula (1") (wherein ???R1 and R2 are each hydrogen atom or optionally substituted aryl, etc.; ???X is -COO- or -CON(R10)-; ???R3 and R4 are each hydrogen atom, C1-C6 alkyl or C1-C6 alkoxy, etc.; ???R5, R6 and R7 are each hydrogen atom, C1-C6 alkyl or C1-C6 alkoxy, etc.; ???R8 and R9 are each independently hydrogen atom, C1-C6 alkyl, -CON(R18)(R19) or -COO(R20), etc.; ???ring A, ring B and ring C are each independently aryl or heterocycle residue, etc.; ???Alk1 and Alk2 are each independently alkanediyl, etc.; ???l and m are each an integer of 0 or 1 to 3) or a prodrug thereof, or a pharmaceutically acceptable salt of either. The therapeutic agent selectively inhibits MTP in the small intestine, thus causes no such side effect as a fatty liver.